Taking Advertising Seriously
Executive Summary
Consumers say they want pharmaceutical advertising to provide them with a lot of information. But top ad execs point out that direct-to-consumer drug advertising is so new, neither they nor FDA knows how it actually works on people.
You may also be interested in...
Probiotics’ Efficacy Too Specific For General Look In ’60 Minutes’ Segment Critical Of Category
A recent segment of CBS News “60 Minutes” discussing potential health benefits from probiotics was highly criticized by groups including the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the International Probiotics Association.
Stada Will Continue To Invest To Drive Growth
After a 12-month period that has seen Stada make significant investments in generics, biosimilars and consumer healthcare, CEO Peter Goldschmidt tells Generics Bulletin that the firm does not intend to stop there, as it pursues both organic and inorganic growth opportunities.
Samsung Bioepis Added To Avastin Biosimilar Litigants
Samsung Bioepis is the latest company to stare down a lawsuit from Genentech over Avastin patents in the US. The Korean firm is aiming to be amongst the early biosimilar movers, after the market formed a year ago.
Need a specific report? 1000+ reports available
Buy Reports